Monographs: Pharmaceutical substances: Albendazole (Albendazole)2024-01
Graphic formula.
Molecular formula. C12H15N3O2S Relative molecular mass. 265.3 Chemical name. Methyl [5-(propylsulfanyl)-1H-1,3-benzimidazol-2-yl]carbamate. CAS Registry Number. 54965-21-8. Description. A white or slightly yellowish powder. Solubility. Practically insoluble in water R; freely soluble in anhydrous formic acid R; very slightly soluble in dichloromethane R, practically insoluble in ethanol (~750 g/L) TS. Category. Anthelminthic. Storage. Albendazole should be kept in a well-closed container, protected from light. Additional information. Albendazole shows polymorphism. Requirements Albendazole contains not less than 99.0% and not more than 101.0% of C12H15N3O2S, calculated with reference to the dried substance. Identity tests
Sulfated ash. Not more than 2 mg/g. Loss on drying. Dry at 105 °C for 4 hours; it loses not more than 5 mg/g. Clarity and colour of solution. Dissolve 0.10 g of the test substance in a mixture of 10 volumes of anhydrous formic acid R and 90 volumes of dichloromethane R and dilute to 10 mL with the same mixture of solvents. This solution is clear and not more intensely coloured than reference solution BY6, when compared as described under 1.11.2 Degree of coloration of liquids, Method II. Heavy metals. Use 1.0 g of the test substance for the preparation of the test solution as described under 2.2.3 Limit test for heavy metals, Procedure 3. Determine the heavy metals content according to Method B; not more than 10 μg/g. Related substances. Prepare the solutions immediately before use. Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography, using a stainless steel column (25 cm × 4.6 mm) packed with end-capped particles of silica gel, the surface of which has been modified with chemically-bonded octadecylsilyl groups (5 µm). As the mobile phase, use a solution prepared as follows: dissolve 1.67 g of ammonium dihydrogen phosphate R in 1000 mL of water R. Mix 300 mL of this solution with 700 mL of methanol R. Operate with a flow rate of 0.7 mL per minute. As a detector, use an ultraviolet spectrophotometer set at a wavelength of 254 nm. Prepare the following solutions. For solution (1), transfer 25.0 mg of the test substance to a 50 mL volumetric flask. Add 5 mL of sulfuric acid/methanol (1%) TS and immediately dilute to volume with the mobile phase. For solution (2), dilute 1.0 mL of solution (1) to 100.0 mL with the mobile phase. For solution (3), dilute 1.0 mL of solution (2) to 10.0 mL with the mobile phase. For solution (4), dissolve 5 mg of albendazole for system suitability RS (containing albendazole and the impurities B, C, E, F and H) in 1 mL of sulfuric acid/methanol (1%) TS and dilute to 10 mL with mobile phase. For solution (5), dilute 1 mL of sulfuric acid/methanol (1%) TS to 10 mL with the mobile phase. Use 1 mL of this solution to dissolve the content of a vial of albendazole impurity mixture RS (containing the impurities A and D). Inject separately 20 µL each of solutions (1), (2), (3), (4) and (5). Record the chromatogram for about twice the retention time of albendazole (retention time about 11 minutes). Use the chromatogram obtained with solution (4) and the chromatogram supplied with albendazole for system suitability RS to identify the peaks due to the impurities B and C, E, F and H. Use the chromatogram obtained with solution (5) and the chromatogram supplied with albendazole impurity mixture RS to identify the peaks due to the impurities A and D. The impurities are eluted at the following relative retention with reference to albendazole: impurity D about 0.35, impurities B and C about 0.40 (the impurities co-elute), impurity E about 0.45, impurity A about 0.48, impurity F about 0.57 and impurity H about 0.66. The test is not valid unless, in the chromatogram obtained with solution (4), the resolution between the peak due to impurities B and C (impurities B and C co-elute) and the peak due to impurity E is at least 1.5. Also, the test is not valid unless in the chromatogram obtained with solution (3), the peak due to albendazole is detected with a signal-to-noise ratio of at least 20. In the chromatogram obtained with solution (1):
Assay. In order to avoid overheating in the reaction medium, mix thoroughly throughout the titration and stop the titration immediately after the endpoint has been reached. Dissolve 0.250 g in 6 mL of anhydrous formic acid R, add 80 mL of glacial acetic acid R1 and titrate with perchloric acid (0.1 mol/L) VS, determining the end-point potentiometrically as described under 2.6 Non-aqueous titration, Method A. Carry out a blank determination and make any necessary correction. Each mL of perchloric acid (0.1 mol/L) VS is equivalent to 26.53 mg of C12H15N3O2S. Impurities
A. 5-(Propylsulfanyl)-1H-1,3-benzimidazol-2-amine (degradation product),
B. Methyl rac-{5-[(R)-propane-1-sulfinyl]-1H-1,3-benzimidazol-2-yl}carbamate (degradation product),
C. Methyl N-[5-(propylsulfonyl)-1H-1,3-benzimidazol-2-yl]carbamate (degradation product),
D. 5-(Propane-1-sulfonyl)-1H-1,3-benzimidazol-2-amine; (degradation product),
E. Methyl (1H-1,3-benzimidazol-2-yl)carbamate (synthesis related impurity),
F. Methyl [5-(methylsulfanyl)-1H-1,3-benzimidazol-2-yl]carbamate (synthesis related impurity),
G. Methyl (5-chloro-1H-1,3-benzimidazol-2-yl)carbamate (synthesis related impurity),
H. Methyl {5-[(2-methyl-4-oxopentan-2-yl)sulfanyl]-1H-1,3-benzimidazol-2-yl}carbamate,
I. Methyl (5-propoxy-1H-1,3-benzimidazol-2-yl)carbamate,
J. Methyl (4,6-dichloro-1H-1,3-benzimidazol-2-yl)carbamate,
K. Methyl [5-(butylsulfanyl)-1H-1,3-benzimidazol-2-yl]carbamate,
L. Methyl {5-[(propan-2-yl)sulfanyl]-1H-1,3-benzimidazol-2-yl}carbamate. |